Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Multiple Acyl Coenzyme A Dehydrogenase Deficiency × Valganciclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solid Tumor, Adult 1 Recurrence 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Multiple Acyl Coenzyme A Dehydrogenase Deficiency 1 Epstein-Barr Virus Infections 1 Advanced Cancer 1

Interventions

Valproic Acid 1 Valganciclovir 1 Gemcitabine 1 Ganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02761291 2016-05-16

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

Chang Gung Memorial Hospital

Phase 1 Unknown

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence, Epstein-Barr Virus Infections, Multiple Acyl Coenzyme A Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡